Dennis Y Chuang1, Jiankun Cui2, Agnes Simonyi3, Victoria A Engel4, Shanyan Chen5, Kevin L Fritsche6, Andrew L Thomas7, Wendy L Applequist8, William R Folk9, Dennis B Lubahn10, Albert Y Sun11, Grace Y Sun12, Zezong Gu13. 1. Interdisciplinary Neuroscience Program, University of Missouri, Columbia, MO, USA Center for Translational Neuroscience, School of Medicine, University of Missouri, Columbia, MO, USA Center for Botanical Interaction Studies, University of Missouri, Columbia, MO, USA. 2. Center for Translational Neuroscience, School of Medicine, University of Missouri, Columbia, MO, USA Center for Botanical Interaction Studies, University of Missouri, Columbia, MO, USA Department of Pathology and Anatomical Sciences, University of Missouri, Columbia, MO, USA Harry S. Truman Memorial Veterans' Hospital, Columbia, MO, USA. 3. Center for Translational Neuroscience, School of Medicine, University of Missouri, Columbia, MO, USA Center for Botanical Interaction Studies, University of Missouri, Columbia, MO, USA Department of Biochemistry, University of Missouri, Columbia, MO, USA. 4. Center for Translational Neuroscience, School of Medicine, University of Missouri, Columbia, MO, USA Department of Pathology and Anatomical Sciences, University of Missouri, Columbia, MO, USA. 5. Interdisciplinary Neuroscience Program, University of Missouri, Columbia, MO, USA Center for Translational Neuroscience, School of Medicine, University of Missouri, Columbia, MO, USA Department of Pathology and Anatomical Sciences, University of Missouri, Columbia, MO, USA. 6. Center for Botanical Interaction Studies, University of Missouri, Columbia, MO, USA Department of Animal Sciences, University of Missouri, Columbia, MO, USA. 7. Center for Botanical Interaction Studies, University of Missouri, Columbia, MO, USA Southwest Research Center, University of Missouri, Mt. Vernon, MO, USA. 8. Center for Botanical Interaction Studies, University of Missouri, Columbia, MO, USA Missouri Botanical Garden, St. Louis, MO, USA. 9. Center for Botanical Interaction Studies, University of Missouri, Columbia, MO, USA Department of Biochemistry, University of Missouri, Columbia, MO, USA. 10. Center for Botanical Interaction Studies, University of Missouri, Columbia, MO, USA Department of Biochemistry, University of Missouri, Columbia, MO, USA Department of Animal Sciences, University of Missouri, Columbia, MO, USA. 11. Center for Translational Neuroscience, School of Medicine, University of Missouri, Columbia, MO, USA Center for Botanical Interaction Studies, University of Missouri, Columbia, MO, USA Department of Pathology and Anatomical Sciences, University of Missouri, Columbia, MO, USA. 12. Center for Translational Neuroscience, School of Medicine, University of Missouri, Columbia, MO, USA Center for Botanical Interaction Studies, University of Missouri, Columbia, MO, USA Department of Pathology and Anatomical Sciences, University of Missouri, Columbia, MO, USA Department of Biochemistry, University of Missouri, Columbia, MO, USA. 13. Center for Translational Neuroscience, School of Medicine, University of Missouri, Columbia, MO, USA Center for Botanical Interaction Studies, University of Missouri, Columbia, MO, USA Department of Pathology and Anatomical Sciences, University of Missouri, Columbia, MO, USA Harry S. Truman Memorial Veterans' Hospital, Columbia, MO, USA guze@health.missouri.edu.
Abstract
Sutherlandia (Sutherlandia frutescens) and elderberry (Sambucus spp.) are used to promote health and for treatment of a number of ailments. Although studies with cultured cells have demonstrated antioxidative and anti-inflammatory properties of these botanicals, little is known about their ability to mitigate brain injury. In this study, C57BL/6 J male mice were fed AIN93G diets without or with Sutherlandia or American elderberry for 2 months prior to a 30-min global cerebral ischemia induced by occlusion of the bilateral common carotid arteries (BCCAs), followed by reperfusion for 3 days. Accelerating rotarod assessment at 24 h after BCCA occlusion showed amelioration of sensorimotor impairment in the mice fed the supplemented diets as compared with the ischemic mice fed the control diet. Quantitative digital pathology assessment of brain slides stained with cresyl violet at 3 days after ischemia/reperfusion (I/R) revealed significant reduction in neuronal cell death in both dietary groups. Immunohistochemical staining for ionized calcium-binding adapter molecule-1 demonstrated pronounced activation of microglia in the hippocampus and striatum in the ischemic brains 3 days after I/R, and microglial activation was significantly reduced in animals fed supplemented diets. Mitigation of microglial activation by the supplements was further supported by the decrease in expression of p47phox, a cytosolic subunit of NADPH oxidase, and phospho-ERK1/2, a mitogen-activated protein kinase known to mediate a number of cytoplasmic processes including oxidative stress and neuroinflammatory responses. These results demonstrate neuroprotective effect of Sutherlandia and American elderberry botanicals against oxidative and inflammatory responses to cerebral I/R.
Sutherlandia (Sutherlandia frutescens) and elderberry (Sambucus spp.) are used to promote health and for treatment of a number of ailments. Although studies with cultured cells have demonstrated antioxidative and anti-inflammatory properties of these botanicals, little is known about their ability to mitigate brain injury. In this study, C57BL/6 J male mice were fed AIN93G diets without or with Sutherlandia or American elderberry for 2 months prior to a 30-min global cerebral ischemia induced by occlusion of the bilateral common carotid arteries (BCCAs), followed by reperfusion for 3 days. Accelerating rotarod assessment at 24 h after BCCA occlusion showed amelioration of sensorimotor impairment in the mice fed the supplemented diets as compared with the ischemicmice fed the control diet. Quantitative digital pathology assessment of brain slides stained with cresyl violet at 3 days after ischemia/reperfusion (I/R) revealed significant reduction in neuronal cell death in both dietary groups. Immunohistochemical staining for ionizedcalcium-binding adapter molecule-1 demonstrated pronounced activation of microglia in the hippocampus and striatum in the ischemic brains 3 days after I/R, and microglial activation was significantly reduced in animals fed supplemented diets. Mitigation of microglial activation by the supplements was further supported by the decrease in expression of p47phox, a cytosolic subunit of NADPH oxidase, and phospho-ERK1/2, a mitogen-activated protein kinase known to mediate a number of cytoplasmic processes including oxidative stress and neuroinflammatory responses. These results demonstrate neuroprotective effect of Sutherlandia and American elderberry botanicals against oxidative and inflammatory responses to cerebral I/R.
Throughout human history, many natural products from plants have been suggested to promote
human health and manage disease symptoms, and some have been developed into modern-day
drugs. Studies in recent years have documented antioxidative and anti-inflammatory
properties of fruits and vegetables and herbs and indicate that some of these can maintain
brain health during aging (Galli et al.,
2002; Sun et al., 2008).
It is important to understand the molecular mechanisms underlying their mode of action.Sutherlandia (Sutherlandia frutescens [L.] R. Brown or Lessertia
frutescens [L.] Goldblatt & J.C. Manning), also known colloquially as cancer
bush, is widely used in southern African traditional and contemporary remedies for a variety
of chronic ailments, including cancer, arthritis, digestive disorders, and diabetes, and
more recently, behavioral symptoms of HIV/AIDS such as depression and anxiety (Mills et al., 2005; van Wyk and Albrecht, 2008). Studies
with cell and animal models have demonstrated its antioxidant and anti-inflammatory
properties (Fernandes et al.,
2004; Ojewole, 2004; Katerere and Eloff, 2005; Kundu et al., 2005; Faleschini et al., 2013; Jiang et al., 2014). Although some
evidence supports Sutherlandia’s benefit for mitigating stress (Prevoo et al., 2004) as well as drug-induced seizures
(Ojewole, 2008), little is
known about its broader effects against neurodegenerative diseases and stroke. Results from
a randomized, double-blind, placebo-controlled trial in healthy adults of consumption of
Sutherlandia for 3 months showed it was well tolerated (Johnson et al., 2007).Consumption of elderberry including the North American subspecies (Sambucus
nigra L. subsp. canadensis [L.] Bolli) has increased in recent
years, mainly for its claimed ability to combat symptoms of common flu and other viral
infections (Zakay-Rones et al.,
1995; “; Vlachojannis et al., 2010). Elderberries are widely
cultivated in Europe, Asia, North Africa, and North America (“). Elderberry fruit contains flavonoids and anthocyanins (Lee and Finn, 2007; Thomas et al., 2013), which are reported to have
beneficial effects of human health, especially cardiovascular functions and
anticarcinogenic, antiviral, and anti-inflammatory effects (Prior and Wu, 2006; Zafra-Stone et al., 2007). Cyanidin-3-glucoside, one
of the most common anthocyanins of berries, was shown to ameliorate ethanol-induced
neurotoxicity in developing brains and protect against focal cerebral ischemia in mice
(Ke et al., 2011; Min et al., 2011). There is further
evidence suggesting the ability of berries to prevent age-associated oxidative stress and to
improve neuronal and cognitive functions in animal models (Galli et al., 2002). Despite the increasing interest
regarding these secondary metabolites, little is known whether elderberries alleviate stroke
damage.Stroke is the second leading cause of death worldwide and is the primary cause of acquired
disability in the United States (Davis
and Donnan, 2012). Although the pathophysiology of ischemic damage is complex,
extensive studies have focused on the underlying mechanisms of oxidative stress and
inflammatory responses following ischemia/reperfusion (I/R; Chen et al., 2011a, 2011b). Studies have demonstrated the role of NADPH
oxidase and activation of the mitogen-activated protein kinase (MAPK) pathways in production
of reactive oxygen species (ROS) and signaling events leading to mitochondrial dysfunction
and activation of apoptotic pathways (Chen et al., 2011a; Yoshioka
et al., 2011a). Among the various in vivo models of cerebral
ischemia, the murine bilateral common carotid artery (BCCA) occlusion model has been
documented to cause damage in the hippocampal and striatal neurons (Lin et al., 2000; Wang et al., 2005b; Yoshioka et al., 2011a). Previous studies with the
gerbil global BCCA occlusion model demonstrated protective effects of botanicals such as
curcumin and grape polyphenol extracts against neuronal cell death and glial cell activation
in the hippocampal CA1 area (Wang
et al., 2002; Simonyi et al.,
2005; Wang et al.,
2005b).Both Sutherlandia and elderberry share the capacity to relieve oxidative stress and
suppress inflammatory responses. In this study, the murineglobal cerebral ischemia model
was used to demonstrate that dietary supplementation by Sutherlandia and American elderberry
offer protection against ischemia-induced neuronal damage and glial cell activation and
neurobehavioral dysfunctions.
Materials and Methods
Materials
Antibodies used for immunohistochemical staining include rabbit anti-p47phox antibody
(sc-14015; Santa Cruz Biotechnology, Santa Cruz, CA) and mouse anti-phospho-ERK1/2
(phosphorylated extracellular signal-regulated kinases 1/2) monoclonal antibody (9102;
Cell Signaling, Beverly, MA). Cell-type-specific antibodies include rat anti-CD11b
(cluster of differentiation molecule 11b, 550274; BD Biosciences, San Jose, CA) and rabbit
anti-Iba-1 (ionizedcalcium-binding adapter molecule-1) antibodies (019-19741; Wako
BioProducts, Richmond, VA) for microglia, and rabbit anti-glial fibrillary acidic protein
(GFAP) antibodies (G9269; Sigma-Aldrich, St. Louis, MO) for astrocytes. Secondary
antibodies include goat anti-mouse IgG-Alexa488 (A11001), goat anti-rabbit IgG Alexa 488
(A110034), goat anti-mouse IgG Alexa fluor 594 (A11005), and goat anti-rat IgG Alexa fluor
594 (A11007; Life Technologies/Invitrogen, Carlsbad, CA).
Animals, Diets, and Ischemia Protocol
Adult male C57Bl/6J mice (The Jackson Laboratory, Bar Harbor, ME) at age 8 weeks were
housed 4/cage and maintained on a 12-h light/dark cycle (lights on at 7:00 a.m.) with
unrestricted access to food and water. Prior to surgical BCCA occlusion, mice were fed for
2 months with a nutritionally complete experimental diet AIN93G with or without supplement
of either 1% by weight of freeze-dried, ground Sutherlandia-dried vegetative material or
2% by weight of freeze-dried, ground whole ripe fruit of American elderberry, based on
empirical estimates of mouse equivalents of human consumption (Wang et al., 2005c; Johnson et al., 2007; see Table 1 for complete composition of the control and
test diets). Sutherlandia vegetative material was purchased from Big Tree Nutraceutical
(Fish Hoek, South Africa) and stored at −20°C in an air-tight container in the dark. The
elderberry fruits were harvested in 2010 from a germplasm repository in southwest Missouri
(United States) and frozen in zippered plastic freezer bags. Berries were later de-stemmed
and cleaned, lyophilized, and ground into fine powder before addition to diets. A mixture
of several American elderberry genotypes was used in this study. Botanical vouchers
confirming the taxonomic identity of plants were deposited into the herbaria of the
University of Missouri or the Missouri Botanical Garden (St. Louis, MO). Average food
intake was 2.6 ± 0.05 g/day/mouse; and average diet consumption was 0.106 ± 0.003 g/gram
body weight/day. Weekly monitoring of body weight indicated no differences in weight
between any of the groups at any time during the course of the study. Approved animal
protocols were obtained, and all treatment steps were in accordance with University of
Missouri and the National Institutes of Health guidelines for the Care and Use of
Laboratory Animals.
Table 1.
Composition of the Control AIN93G and Diets Supplemented With Sutherlandia and
Elderberry.
Ingredient
Control diet
1% Sutherlandia diet
2% Elderberry diet
g/kg of diet
% of total
g/kg of diet
% of total
g/kg of diet
% of total
Cornstarch
397.3
39.73
387.3
38.73
387.3
37.73
Casein
200.0
20.00
200.0
20.00
200.0
20.00
Dextrose
132.0
13.20
132.0
13.20
132.0
13.20
Sucrose
100.0
20.00
100.0
10.00
100.0
10.00
Fiber (cellulose)
50.0
5.00
50.0
5.00
50.0
5.00
Mineral mix (AIN-93)
35.0
3.50
35.0
3.50
35.0
3.50
Vitamin mix (AIN-93G)
10.0
1.00
10.0
1.00
10.0
1.00
l-cystine
3.0
0.30
3.0
0.30
3.0
0.30
Choline bitartrate
2.5
0.25
2.5
0.25
2.5
0.25
Soybean oil
70.0
7.00
70.0
7.00
70.0
7.00
Food dye (color varies)
0.2
0.02
0.2
0.02
0.2
0.02
Elderberry (whole ripe fruit)[a]
–
–
–
–
20
2.00
Sutherlandia (dried leaves)[b]
–
–
10
1.00
–
–
Total
1,000
100
1,000
100
1,000
100
York and Bob Gordon cultivars (60:40 ratio) were harvested at the peak of
ripeness, freeze-dried, then ground into a fine powder, and mixed with an equal
weight of corn starch to prevent clumping. The amount of this mix added to the
diet was actually twice that shown in the table.
Sutherlandia was sourced Big Tree Nutraceutical (21 First Avenue, Fish Hoek 7975,
South Africa). Prior to its incorporation into the diet, the chopped leaves were
grounded into a fine powder using a handheld coffee bean grinder.
Composition of the Control AIN93G and Diets Supplemented With Sutherlandia and
Elderberry.York and Bob Gordon cultivars (60:40 ratio) were harvested at the peak of
ripeness, freeze-dried, then ground into a fine powder, and mixed with an equal
weight of corn starch to prevent clumping. The amount of this mix added to the
diet was actually twice that shown in the table.Sutherlandia was sourced Big Tree Nutraceutical (21 First Avenue, Fish Hoek 7975,
South Africa). Prior to its incorporation into the diet, the chopped leaves were
grounded into a fine powder using a handheld coffee bean grinder.For the study, mice were divided into four experimental groups: (a) sham animals with
AIN93G control diet (Sham/CD, n = 7), (b) BCCA occlusion-induced ischemia
with AIN93G diet (Isch/CD, n = 7), (c) BCCA occlusion-induced ischemia
with AIN93G diet containing 1% Sutherlandia (Isch/SD, n = 7), and (d)
BCCA occlusion-induced ischemia with AIN93G diet containing 2% elderberry (Isch/ED,
n = 7). To conserve on animal numbers, sham operation was performed
only on animals with the control diet. Animals were subjected to a transient global
cerebral ischemia by BCCA occlusion as described previously with minor modifications
(Lin et al., 2000; Chen et al., 2011a). To initiate the
surgical protocol, mice were placed in a holding chamber and anesthetized with 4%
isoflurane, and continuous anesthesia during surgery was maintained with 1% to 1.5%
isoflurane in 70% nitrogen and 30% oxygen with a face mask. During the surgery, rectal
temperature was monitored and maintained at 37 ± 0.5°C with a thermostat-controlled
heating pad. BCCA occlusion was accomplished by applying microaneurysm clips on both
common carotid arteries for 30 min followed by release of the clips and a 3-day
reperfusion. Reestablishment of blood flow was confirmed by direct observation. Sham
operation animals were subjected to the identical surgical procedures except for
application of micro-aneurysm clips. After surgery, animals were placed in cages above a
heating blanket to maintain rectal temperatures above 36°C for 1–2 h with active
monitoring.
Assessment of Sensorimotor Functions
Assessment of sensorimotor functions was carried out by the rotarod test as described
previously with modifications (Simonyi
et al., 2012). Two days prior to BCCA occlusion, mice were trained on the rotarod
(Med Associates, St. Albans, VT) in the acceleration paradigm (4–40 rpm/5 min) for three
trials each day with a 30-min intertrial interval (see Figure 1(a) for the experimental design with BCCA
occlusion set as Day 0). Latency is defined as the time spent on the accelerating rotating
rotarod without falling off or gripping and spinning rather than walking. Preoperative
baseline values were obtained by determining average of the three best performances.
Postoperative testing (three trials) were performed 24 h after I/R, and the means were
used for calculation of rotarod performance. Latencies measured at 24 h after I/R were
expressed as % of performances reached before surgery.
Figure 1.
Supplementation of Sutherlandia and elderberry diets and assessment of motor
coordination and balance functions in ischemic mice.
(a) Experimental design for dietary feeding, rotarod assessment, and BCCA occlusion
(BCCAo). (b) Accelerating rotarod assessment reveals amelioration of behavioral
deficits from transient global cerebral ischemia by dietary supplement of
Sutherlandia and elderberry. Rotarod performance is expressed as percent of time the
mouse can stay on the accelerating rotarod compared with pre-ischemia as the
baseline values. Four groups of mice were divided into (i) AIN93G control diet
(Sham/CD), (ii) BCCA occlusion-induced ischemia with control diet (Isch/CD), (iii)
BCCA occlusion-induced ischemia + Sutherlandia diet (Isch/SD), and (iv) BCCA
occlusion-induced ischemia + elderberry diet (Isch/ED). Data are expressed as
mean ± SEM (n = 7 for all groups). Statistical
significance is denoted with ***p < .001 (compared with
Sham/CD); ^p < .05 and ^^p < .01 (compared
with Isch/CD) by one-way ANOVA followed by Bonferroni’s posttest.
Supplementation of Sutherlandia and elderberry diets and assessment of motor
coordination and balance functions in ischemicmice.(a) Experimental design for dietary feeding, rotarod assessment, and BCCA occlusion
(BCCAo). (b) Accelerating rotarod assessment reveals amelioration of behavioral
deficits from transient global cerebral ischemia by dietary supplement of
Sutherlandia and elderberry. Rotarod performance is expressed as percent of time the
mouse can stay on the accelerating rotarod compared with pre-ischemia as the
baseline values. Four groups of mice were divided into (i) AIN93G control diet
(Sham/CD), (ii) BCCA occlusion-induced ischemia with control diet (Isch/CD), (iii)
BCCA occlusion-induced ischemia + Sutherlandia diet (Isch/SD), and (iv) BCCA
occlusion-induced ischemia + elderberry diet (Isch/ED). Data are expressed as
mean ± SEM (n = 7 for all groups). Statistical
significance is denoted with ***p < .001 (compared with
Sham/CD); ^p < .05 and ^^p < .01 (compared
with Isch/CD) by one-way ANOVA followed by Bonferroni’s posttest.
Brain Tissue Processing, Histochemical Staining, and Assessment of Neuronal
Damage
Three days after I/R, mice were euthanized with isoflurane and brains were sectioned for
histochemical staining and assessment of neuronal damage using a well-established protocol
as described previously (Cui et al.,
2012; Hadass et al.,
2013). Briefly, mice were transcardially perfused with 4% paraformaldehyde in
100-mM phosphate buffer, and brains were dissected and preserved for 24 h in the same
buffer. Serial coronal sections (40 µm) were obtained with a vibrotome (VT1200S, Leica
Microsystems, Inc., Bannockbum, IL). In most instances, a total of 150 to 160 40-µm tissue
sections from each brain were collected into 24-well plates. Serial brain sections 200-µm
apart were mounted on poly-l-lysine-coated glass slides and followed by staining
with cresyl violet, a stain for Nissl substance in the cytoplasm of neurons commonly used
for assessment of neuronal cell death.Pathological assessment of histological specimens was carried out in an unbiased manner
using a high-throughput digital pathology system. Briefly, whole slide images (WSI) of the
cresyl violet-stained brain sections were obtained using an automatic multifocus plane,
high-throughput digital pathology system (Aperio ScanScope CS digital scanner, Vista, CA).
Extent of neuronal damage in the brain sections were analyzed in a double-blind manner
using the following criteria for the grading scale: 0: no observable neuronal
damage; 1: damaged neurons populate 0% to 25% of area; 2:
damaged neurons populate 25% to 50% of area; 3: damaged neurons
populate 50% to 75% of area; and 4: damaged neurons populate >75% of
area (Cui et al.,
2012; Hadass et al.,
2013).
Fluorescence Immunohistochemistry
Fluorescence immunohistochemistry was carried out on brain sections for astrocytes (with
GFAP) and microglia (with Iba-1 and CD11b; Hadass et al., 2013), as well as p47phox and
phospho-ERK1/2. Briefly, fixed coronal sections from the area of interest were washed with
phosphate-buffered saline (PBS) and permeabilized with 1% Triton X-100 in PBS for 30 min.
Sections were incubated with Pro-Block (PBK125; ScyTek, Logan, UT) for 5 min to eliminate
the need to match species with the fluorescence conjugated antibody, followed by 10%
normal goat serum in 0.05% Triton X-100 in PBS for 60 min, and then overnight with 0.5%
normal goat serum in 0.05% Triton X-100 in PBS containing the primary antibodies (GFAP,
1:500; CD11b, 1:400; Iba-1, 1:1000; p47phox, 1:400; and phospho-ERK 1:500). The next day,
sections were washed and incubated in 0.05% Triton X-100 in PBS containing the appropriate
fluorophore-conjugated secondary antibodies (1:300; goat anti-mouse IgG-Alexa488, goat
anti-mouse IgG-Alexa594, and goat anti-rabbit IgG-Alexa488, goat anti-rat IgG Alexa594;
Life Technologies/Invitrogen, San Diego, CA) for 2 h and counterstained in a solution of
Hoechst dye 33342 (1:1000; H-3570, Life Technologies/Invitrogen, San Diego, CA).
Fluorescence photomicrographs of the areas of interest were captured by a Leica DMI 6000B
automated epifluorescence microscope (Leica Microsystems Inc., Buffalo Grove, IL), and the
high magnification photomicrographs were processed using the AF6000 stitching program and
intensity analysis with the ImageJ program. For quantification of immunofluorescence
intensity, five representative areas in the striatum (coordinated approximately to Bregma
0.78 mm) were selected bilaterally (as indicated in the Figure 4(a)), and the microphotographic images of the
immunostained brain sections were captured. All microphotographic images for examining
each set of the experimental groups were taken under the same camera and microscope
settings including the dimension, voxel size, and exposure parameters (intensity, exposure
time and gain for each channel, as well as threshold values for black as 0, white as 255,
and binning 1 × 1), except pERK which has threshold values from 99 to 255.
Figure 4.
Consumption of Sutherlandia and elderberry diets attenuates activation of
microglial cells but not astrocytes in the striatal regions after transient global
cerebral ischemia.
(a) Graphical illustration of the five representative areas selected bilaterally
for captured intensity analysis. (b) Representative fluorescent microscopic images
of Iba-1 immunoreactivity among all groups; Scale bar = 100 µm. Inset in Sham/CD
panel shows representative cells of the ramified resting microglia, while inset in
Isch/CD panel shows the amoeboid form of activated microglia; Scale bar = 25 µm.
Quantitation of the average fluorescent intensity for Iba1 (c) and GFAP (d)
immunoreactivity from five areas in the striatum (n = 5 for all
groups). Data are expressed as means ± SEM. Statistical
significance is denoted with *p < .05,
***p < .001 (compared with Sham/CD); and
^^^p < .001 (compared with Isch/CD) by one-way ANOVA followed by
Bonferroni’s posttest.
Statistical Analysis
Data are presented as mean ± standard error of the mean (SEM). Results
were analyzed by one-way analysis of variance (ANOVA) with Bonferroni’s posttest (V4.00;
GraphPad Prism Software Inc., San Diego, CA). Statistical significance was considered for
p < .05.
Results
Dietary Supplementation With Sutherlandia or Elderberry Ameliorated Motor Impairment
in Mice After Transient Global Cerebral Ischemia
A time line of the experimental protocol, showing feeding of mice at 2 months of age,
presurgery and postsurgery rotarod tests, and sacrifice for brain pathology is shown in
Figure 1(a). In this experiment,
sensorimotor functions in the sham, ischemia, and ischemia with Sutherlandia and
elderberry diet groups were assessed using the accelerating rotarod paradigm. In the
pre-ischemia rotarod tests, no differences were observed in sensorimotor functions between
controls and the different dietary groups (Sham/CD, 254.0 + 5.9 s; Isch/CD,
245.6 + 10.7 s; Isch/SD, 247.0 + 12.5 s; Isch/ED, 275.7 + 6.2 s;
p > .05, one-way ANOVA). Rotarod performance was unchanged in the
sham-operated group but was significantly impaired in the ischemia group assessed 24 h
after reperfusion (Figure 1(b)).
Consumption of the Sutherlandia or elderberry supplemented diets for 2 months ameliorated
the sensorimotor deficits by prolonging rotarod latencies.
Consumption of Sutherlandia and Elderberry Diets Decreased Neuronal Damage After
I/R
Cresyl violet staining of brain sections revealed substantial damage in neuronal
morphology after BCCA occlusion (Figure
2(a)): While normal healthy neurons were round with pale-stained cytoplasm, many
neurons in the ischemic regions in cortex, hippocampus, and striatum were angular in shape
with condensed cell bodies (see higher magnification insets in Figures 2(b), (d), and (f), respectively). The zoomable WSI photomicrographs
were acquired from approximately 30 to 35 serial tissue sections with 200-µm interval per
brain. Damage scoring (0–4, based on the criteria described in the Materials and Methods
section) for cerebral cortex, hippocampus, and striatum including thalamus and basal
ganglia areas were carried out in a double-blind manner using the web-based ImageScope
program. Quantitation of the cellular damage in each region revealed that I/R resulted in
severe neuronal damage in the hippocampal but those in the striatum/thalamus/basal ganglia
area and the cortical regions were also damaged albeit to a lesser extent (Figure 2(b) and (c)). Dietary supplementation with elderberry
significantly decreased the neuronal damage in all the brain regions examined (Figure 2(c), (e), and (g)). To a lesser extent, decrease in neuronal damage
was also observed in these brain regions on supplementation with Sutherlandia.
Figure 2.
Consumption of Sutherlandia and elderberry diets ameliorates neuronal damage after
transient global cerebral ischemia.
(a) Representative photomicrographs of serial brain sections with each 960-µm
apart; Scale bar = 3 mm. (b, d, and f) Representative images of neurons from cortex,
hippocampus, and the striatal/thalamus/basal ganglia areas; Scale bar = 100 µm, and
50 µm for the inset. (c, e, and g) Graphical presentation of neuropathology scores
in the respective brain regions (0 = no damage; 4 = maximal
damage). Data are expressed as mean ± SEM, where
n = 7 animals from each group. Statistical significance is
denoted with ***p < .001 (compared with Sham/CD);
^p < .05, ^^p < .01, and
^^^p < .001 (compared with Isch/CD) with one-way ANOVA
followed by Bonferroni’s posttest.
Consumption of Sutherlandia and elderberry diets ameliorates neuronal damage after
transient global cerebral ischemia.(a) Representative photomicrographs of serial brain sections with each 960-µm
apart; Scale bar = 3 mm. (b, d, and f) Representative images of neurons from cortex,
hippocampus, and the striatal/thalamus/basal ganglia areas; Scale bar = 100 µm, and
50 µm for the inset. (c, e, and g) Graphical presentation of neuropathology scores
in the respective brain regions (0 = no damage; 4 = maximal
damage). Data are expressed as mean ± SEM, where
n = 7 animals from each group. Statistical significance is
denoted with ***p < .001 (compared with Sham/CD);
^p < .05, ^^p < .01, and
^^^p < .001 (compared with Isch/CD) with one-way ANOVA
followed by Bonferroni’s posttest.
Immunostaining of Microglial Cells and Astrocytes
Neuronal damage after I/R is often accompanied with increased neuroinflammatory responses
including astrogliosis and microglial activation (Wang et al., 2006; Brennan et al., 2009; Chen et al., 2011b). We assessed these responses 3
days after I/R by immunostaining brain sections with Iba-1 for microglia and GFAP for
astrocytes. Immunofluorescent analysis with Iba-1 revealed low immunoreactivity in sham
controls but a robust and widespread increase in the ischemic brain, especially in the
hippocampal and striatal regions (Figure
3(a), Isch/CD). Both Sutherlandia and elderberry diets attenuated the Iba-1
immunoreactivity in the cortex and striatum (Figure 3(a), Isch/SD and Isch/ED).
Figure 3.
Brain sections immunostained with Iba-1 and GFAP.
Microphotographs were generated by fluorescent microscope at resolution of
40× magnification for entire section regions, followed by automatic stitching of
borders. (a) Representative brain fluorescent microscopic images of Iba-1 expression
in the sham-operated mice with the control diet (Sham/CD), and the ischemic animals
with the control diet (Isch/CD), Sutherlandia diet (Isch/SD), and elderberry diet
(Isch/ED). (b) Representative whole-brain fluorescent microscopic images of GFAP
expression in the sham-operated mice with the control diet (Sham/CD), and the
ischemic animals with the control diet (Isch/CD), Sutherlandia diet (Isch/SD), and
elderberry diet (Isch/ED). Scale bar = 1.00 mm in (a) and (b).
Brain sections immunostained with Iba-1 and GFAP.Microphotographs were generated by fluorescent microscope at resolution of
40× magnification for entire section regions, followed by automatic stitching of
borders. (a) Representative brain fluorescent microscopic images of Iba-1 expression
in the sham-operatedmice with the control diet (Sham/CD), and the ischemic animals
with the control diet (Isch/CD), Sutherlandia diet (Isch/SD), and elderberry diet
(Isch/ED). (b) Representative whole-brain fluorescent microscopic images of GFAP
expression in the sham-operatedmice with the control diet (Sham/CD), and the
ischemic animals with the control diet (Isch/CD), Sutherlandia diet (Isch/SD), and
elderberry diet (Isch/ED). Scale bar = 1.00 mm in (a) and (b).We also examined brain sections immunostained with GFAP as a marker for activated
astrocytes. Immunoreactivity of GFAP was low in sham controls but increased after I/R. The
pattern for GFAP immunoreactivity appeared to be more spread out and diffuse as compared
with those stained with Iba-1 immunoreactivity (Figure 3(b)).
Sutherlandia and Elderberry Consumption Attenuated I/R-Induced Activation of
Microglia but Not Astrocytes in the Striatum
Because the striatal region is more homogeneous, we selected five representative
subregions for further examine cell immunoreactivity and morphology (Figure 4(a)). Immunoreactivity of Iba-1 expressing
microglial cells in the sham-operated group appeared mostly in the resting ramified form
with small round cell bodies and thin processes (Figure 4(b)), whereas those in the ischemic regions
became amoeboid shape with irregular cell bodies and thick processes (see insets in Figure 4(b)). By assessing average
fluorescence intensity of Iba-1 in these striatal regions, significantly lower
immunoreactivity of microglia in mice fed the Sutherlandia or elderberry diets as compared
with the ischemia group on the control diet (Figure 4(c)).Consumption of Sutherlandia and elderberry diets attenuates activation of
microglial cells but not astrocytes in the striatal regions after transient global
cerebral ischemia.(a) Graphical illustration of the five representative areas selected bilaterally
for captured intensity analysis. (b) Representative fluorescent microscopic images
of Iba-1 immunoreactivity among all groups; Scale bar = 100 µm. Inset in Sham/CD
panel shows representative cells of the ramified resting microglia, while inset in
Isch/CD panel shows the amoeboid form of activated microglia; Scale bar = 25 µm.
Quantitation of the average fluorescent intensity for Iba1 (c) and GFAP (d)
immunoreactivity from five areas in the striatum (n = 5 for all
groups). Data are expressed as means ± SEM. Statistical
significance is denoted with *p < .05,
***p < .001 (compared with Sham/CD); and
^^^p < .001 (compared with Isch/CD) by one-way ANOVA followed by
Bonferroni’s posttest.Similarly, fluorescence intensity of GFAP in the striatal regions indicated a significant
increase in GFAP immunoreactivity after BCCA occlusion as compared with sham controls
(Figure 4(d)). However, both
Sutherlandia and elderberry diets did not attenuate GFAP immunoreactivity as compared with
the ischemia group on the control diet (Figure 6(d)).
Figure 6.
Immunostaining showing increase in p47phox expression in ischemic brain and
attenuation by consumption of Sutherlandia and elderberry diets.
(a) Representative fluorescent microscopic images of p47phox expression among four
groups: Sham/CD, Isch/CD, Isch/SD, and Isch/ED; Scale bar = 100 µm. (b) Graphical
presentation of the average fluorescent intensity from five areas of interest
(n = 5 for all groups). Data are expressed as
mean ± SEM. Statistical significance is denoted with
***p < .001 (compared with Sham/CD);
^p < .05 and ^^p < .01 (compared with
Isch/CD) by one-way ANOVA followed by Bonferroni’s posttest.
Sutherlandia and Elderberry Consumption Inhibited I/R-Induced Increases in p47Phox
Expression in the Striatum
A number of studies have demonstrated involvement of NADPH oxidase in ROS production
during I/R (Wang et al., 2006;
Chen et al., 2009). Double
immunostaining of p47phox, an NADPH oxidase subunit, with GFAP for astrocytes and CD11b
for microglial cells showed that p47phox immunoreactivity did not colocalize with the GFAP
expressing astrocytes (Figure
5(a)), but instead with the CD11b expressing microglia (Figure 5(b)).
Figure 5.
P47phox expression colocalized with microglia, and not astrocytes, in the striatum
at 72 h after ischemia/reperfusion.
(a) Fluorescent microscopic image of p47phox (green) and GFAP (red) staining
showing no colocalization between the p47phox and astrocytes. (b) Fluorescent
microscopic image of p47phox (green) and CD11b (red) staining showing colocalization
between the p47phox and microglia; Scale bar = 100 µm in a and b.
P47phox expression colocalized with microglia, and not astrocytes, in the striatum
at 72 h after ischemia/reperfusion.(a) Fluorescent microscopic image of p47phox (green) and GFAP (red) staining
showing no colocalization between the p47phox and astrocytes. (b) Fluorescent
microscopic image of p47phox (green) and CD11b (red) staining showing colocalization
between the p47phox and microglia; Scale bar = 100 µm in a and b.Quantitation of the p47phox immunoreactivity was carried out in the five selected areas
in the bilateral striatal regions. A significant increase in p47phox immunoreactivity was
observed in the striatum (Figure
6(a)) as well as in the hippocampus (data not shown) of the ischemic brain at 3
days after I/R. Measurement of fluorescent intensity from different areas in the striatal
and caudate putamen region indicated that mice given either botanical diet had a
significant decrease in p47phox immunoreactivity as compared with the ischemic group
(Figure 6(b)).Immunostaining showing increase in p47phox expression in ischemic brain and
attenuation by consumption of Sutherlandia and elderberry diets.(a) Representative fluorescent microscopic images of p47phox expression among four
groups: Sham/CD, Isch/CD, Isch/SD, and Isch/ED; Scale bar = 100 µm. (b) Graphical
presentation of the average fluorescent intensity from five areas of interest
(n = 5 for all groups). Data are expressed as
mean ± SEM. Statistical significance is denoted with
***p < .001 (compared with Sham/CD);
^p < .05 and ^^p < .01 (compared with
Isch/CD) by one-way ANOVA followed by Bonferroni’s posttest.
Sutherlandia and Elderberry Consumption Inhibited I/R-Induced Phospho-ERK1/2
Expression in Microglial Cells
Recent studies with cultured microglial cells demonstrated involvement of ERK1/2 in the
oxidative/nitrosative pathways associated with stimulation by lipopolysaccharide (LPS) and
interferon gamma (IFNγ; Chuang et al.,
2013). Based on the observations of increased p47phox immunoreactivity and
activated microglial cells in striatum after I/R, we further examined phospho-ERK1/2
expression in the ischemic brain sections and compared immunoreactivity with the groups
supplemented with Sutherlandia and elderberry diets. Double immunostaining for
phospho-ERK1/2 and microglial marker CD11b indicated increased phospho-ERK1/2
immunoreactivity colocalized with many microglial cells in the striatum at 3 days after
I/R (Figure 7(a)). Fluorescence
intensity analysis showed significant decrease in phospho-ERK1/2 immunoreactivity in both
dietary groups as compared with the ischemia control group (Figure 7(b) and (c)).
Figure 7.
Increase in phospho-ERK1/2 expression in ischemic brain and attenuation by
consumption of Sutherlandia and elderberry diets.
The increased phospho-ERK1/2 (p-ERK1/2) expression is colocalized with microglia.
(a) Fluorescent microscopic image of p-ERK1/2 (green) and CD11b (red) staining
showing colocalization between the p-ERK1/2 and microglia in the Isch/CD condition.
(b) Representative fluorescent microscopic images of p-ERK1/2 expression among all
groups. Scale bar = 100 µm in (a) and (b). (c) Graphical presentation of the average
fluorescent intensity from five areas of interest (n = 5 animals
were selected randomly for seven in all groups). Data are expressed as
mean ± SEM. Statistical significance is denoted with
***p < .001 (compared with Sham/CD);
^^p < .01 and ^^^p < .001 (compared with
Isch/CD) with by one-way ANOVA followed by Bonferroni’s posttest.
Increase in phospho-ERK1/2 expression in ischemic brain and attenuation by
consumption of Sutherlandia and elderberry diets.The increased phospho-ERK1/2 (p-ERK1/2) expression is colocalized with microglia.
(a) Fluorescent microscopic image of p-ERK1/2 (green) and CD11b (red) staining
showing colocalization between the p-ERK1/2 and microglia in the Isch/CD condition.
(b) Representative fluorescent microscopic images of p-ERK1/2 expression among all
groups. Scale bar = 100 µm in (a) and (b). (c) Graphical presentation of the average
fluorescent intensity from five areas of interest (n = 5 animals
were selected randomly for seven in all groups). Data are expressed as
mean ± SEM. Statistical significance is denoted with
***p < .001 (compared with Sham/CD);
^^p < .01 and ^^^p < .001 (compared with
Isch/CD) with by one-way ANOVA followed by Bonferroni’s posttest.
Discussion
This study demonstrates that dietary Sutherlandia and elderberry mitigate behavioral
deficits and pathology induced by BCCA occlusion in mice. These results agree with and
extend our earlier studies using the Mongolian gerbil model demonstrating botanicals such as
curcumin, apocynin, and grape polyphenols protect against ischemic damage (Wang et al., 2005a, 2005b, 2006, 2009). With the gerbil model, BCCA occlusion for
5 min causes extensive neuron cell death and glial activation in the hippocampal CA1 area 4
days after I/R (Wang et al.,
2002). More recent studies by others using the murine model, and BCCA occlusion for
22 min resulted in damage in the hippocampal area as well as the striatal area (Yoshioka et al., 2011b). In the
present study, we adopted the moderately severe murine BCCA occlusion model to investigate
effects of dietary Sutherlandia and elderberry on I/R injury. BCCA occlusion for 30 min and
followed by reperfusion for 3 days resulted in severe neuronal damage in the hippocampus,
and sporadic cell death in the cortex as well as in the striatal/thalamus/basal ganglion
regions. Using digital pathology and the 5-point scoring system on cresyl violet-stained
brain sections, the results demonstrated dietary Sutherlandia and elderberry significantly
mitigate the I/R-induced neuronal damage in all three brain regions. A behavioral test using
the accelerating rotarod paradigm to monitor sensorimotor deficits of individual animals
further showed that dietary supplementation of Sutherlandia and elderberry significantly
ameliorated the I/R-induced motor/coordination deficits.Cerebral ischemia not only causes damage to neurons but also activates glial cells, both
astrocytes and microglia. In previous studies with the gerbil model, a 5-min BCCA occlusion
followed by reperfusion for 4 days led to prominent activation of astrocytes and microglial
cells around the hippocampal CA1 region, where pyramidal neurons are extensively damaged
(Wang et al., 2005a, 2009). With this murine model, we
observed substantially greater activation of microglial cells at 3 days after a 30-min BCCA
occlusion. The pattern of microglial cells activation reflects the areas where neurons are
damaged. Alteration in microglial cell morphology toward the phagocytic form at this time
after reperfusion is in agreement with the notion that microglia are actively responding to
neuronal injury and cell death. The observation that mice consuming the Sutherlandia or
elderberry diets showed significantly less microglial activation as compared with the
ischemic brains of mice consuming control diet supports the capacity of these diets to
mitigate neuron damage and microglial activation.With the BCCA occlusion model, significant increase in astrocytes can be observed in the
ischemic brain 3 days after I/R. Unlike the focal ischemia model where extensive
astrogliosis is found in the penumbral area, astrocytes in the BCCA brain are more
widespread in different brain regions. Furthermore, there is no significant difference in
GFAP immunoreactivity comparing ischemicmice given the Sutherlandia or elderberry diets
with control diets. These results further demonstrate effects of Sutherlandia and elderberry
to protect ischemic damage through inhibiting neuron cell death and microglial cell
activation. Although these results suggest an intimate relationship between neuronal damage
and activation of microglial cells, more studies are needed to better understand mode of
communication between these two cell types.Increase in oxidative stress is an important factor in reperfusion injury; and several
studies have implicated the involvement of NADPH oxidase as an important source of ROS
(Chen et al., 2009; Yoshioka et al., 2011a). Although
mechanisms for ROS produced by NADPH oxidase in neurons and glial cells are not well
understood, our and other’s studies (Brennan et al., 2009) demonstrated rapid production of ROS in primary neurons
(minutes) on stimulation by the ionotropic glutamate receptor agonist
(N-methyl-d-aspartic acid, NMDA; Shelat et al., 2008); however, production of ROS in
microglial cells follows a delayed process in hours (Chuang et al., 2013). When botanicals such as honokiol
and Sutherlandia extract were used to test antioxidative effect on neurons (stimulated with
NMDA) and microglial cells (stimulated with LPS), neurons were more sensitive to the
antioxidative action than microglial cells (Chuang et al., 2013; Jiang et al., 2014). The role of NADPH oxidase in ROS
production in neurons was demonstrated by using neurons from p47phox-deficient mice, which
showed diminished response to ROS production in response to excitotoxic agents (Brennan et al., 2009). In the mouse
model of global cerebral ischemia, an increase in p47phox immunoreactivity was observed in
mouse striatum 3 days after I/R (Yoshioka et al., 2011a). In the present study, we further localize the I/R-induced
increase in p47phox immunoreactivity to microglial cells. Again, the significantly lower
expression of p47phox immunoreactivity in mice given the Sutherlandia and elderberry diets
as compared with that given the control diet is in agreement with the observation of
decreased microglia activation.It has been reported that I/R stimulates activation of MAPK pathways, in particular, the
p38 MAPK and the Ras/MEK signaling (Nito
et al., 2008), which are attributed to activation of the aquaporin-4 channel
responsible for astrocyte swelling (Nito
et al., 2012). Other studies also demonstrated upregulation of the MAPK/ERK1/2
pathway in brain after stroke (Sawe
et al., 2008; Yenari et al.,
2010). In fact, ERK1/2 is regarded as the most important member of the MAPK family
capable of mediating a range of cellular responses, including motility, inflammation, and
cell survival as well as cell death (Sawe et al., 2008). In our recent study with microglial cells, IFNγ not only
stimulates the canonical Janus kinase-Signal Transducer and Activator of Transcription
(JAK-STAT) pathway but also the MAPK/ERK1/2 pathway, and in turn, phospho-ERK1/2 is linked
to activation of a number of cytoplasmic proteins including p47phox of NADPH oxidase for ROS
and inducible nitric oxide synthase (iNOS) for nitric oxide (NO) production (Chuang et al., 2013). Subsequently,
inhibition of phospho-ERK1/2 by U0126 abrogated IFNγ-induced NO and ROS production pin a
dose-dependent manner (Chuang et al.,
2013). Our recent study also demonstrated the capacity of Sutherlandia extracts to
inhibit IFNγ-induced phospho-ERK1/2 and subsequently mitigate ROS and NO production in
microglial cells (Jiang et al.,
2014). Botanical polyphenols, for example, the active ingredient of green tea,
epigallocatechin-3-gallate, also attenuates NO production through downregulation of
ERK1/2-associated proteins including ALDH2, ANXA1, and LGALS1 in LPS-stimulated BV-2
microglial cells (Qu et al.,
2014). Other studies also demonstrate a critical role of the MAPK/ERK pathway in
neuron excitation (Simon et al.,
1984) and MEK/ERK inhibitors mitigating brain damage in the stroke model (Wang et al., 2003, 2004; Gladbach et al., 2013). Results of this study further
support the important role of phospho-ERK1/2 expression in microglial cells after I/R, and
suppression in mice fed diets supplemented with Sutherlandia and elderberry.Because Sutherlandia is widely used in southern Africa for symptoms of HIV/AIDS and
elderberry dietary supplements are among top selling products in Europe and North America,
these studies provide new insights into use of these herbs as neuroprotective agents. In
summary, we have demonstrated significant protective effects of dietary elderberry and
Sutherlandia against global cerebral ischemia-induced functional motor deficits and
neuropathological changes, including neuronal cell death and microglial activation. Results
further support the hypotheses that these botanicals exert beneficial effects against
ischemic damage through suppression of oxidative and proinflammatory pathways in neurons and
microglial cells. This study provides strong rationale to further investigate the active
components and mechanisms of action and to determine whether their consumption ameliorates
ischemic damage as well as neurodegenerative diseases.
Summary
This study demonstrates that Sutherlandia and American elderberry botanicals ameliorate
ischemia/reperfusion (stroke)-induced behavioral dysfunction, neuronal damage, and oxidative
stress and inflammatory responses in microglial cells.
Authors: Qun Wang; Kenneth D Tompkins; Agnes Simonyi; Ronald J Korthuis; Albert Y Sun; Grace Y Sun Journal: Brain Res Date: 2006-05-02 Impact factor: 3.252
Authors: Dennis Y Chuang; Ming-Huan Chan; Yijia Zong; Wenwen Sheng; Yan He; Jing Hua Jiang; Agnes Simonyi; Zezong Gu; Kevin L Fritsche; Jiankun Cui; James C Lee; William R Folk; Dennis B Lubahn; Albert Y Sun; Grace Y Sun Journal: J Neuroinflammation Date: 2013-01-29 Impact factor: 8.322
Authors: William R Folk; Aaron Smith; Hailong Song; Dennis Chuang; Jianlin Cheng; Zezong Gu; Grace Sun Journal: Neuromolecular Med Date: 2016-05-07 Impact factor: 3.843
Authors: Deepa Ajit; Agnes Simonyi; Runting Li; Zihong Chen; Mark Hannink; Kevin L Fritsche; Valeri V Mossine; Robert E Smith; Thomas K Dobbs; Rensheng Luo; William R Folk; Zezong Gu; Dennis B Lubahn; Gary A Weisman; Grace Y Sun Journal: Neurochem Int Date: 2016-05-07 Impact factor: 3.921
Authors: Shanyan Chen; Fanjun Meng; Zhenzhou Chen; Brittany N Tomlinson; Jennifer M Wesley; Grace Y Sun; Adam T Whaley-Connell; James R Sowers; Jiankun Cui; Zezong Gu Journal: PLoS One Date: 2015-04-10 Impact factor: 3.240
Authors: Bo Yang; Runting Li; Pei N Liu; Xue Geng; Brian P Mooney; Chen Chen; Jianlin Cheng; Kevin L Fritsche; David Q Beversdorf; James C Lee; Grace Y Sun; C Michael Greenlief Journal: J Proteome Res Date: 2020-04-27 Impact factor: 4.466
Authors: Grace Y Sun; Xue Geng; Tao Teng; Bo Yang; Michael K Appenteng; C Michael Greenlief; James C Lee Journal: Cells Date: 2021-10-30 Impact factor: 6.600
Authors: Haydee Lara; Zaibo Li; Esther Abels; Famke Aeffner; Marilyn M Bui; Ehab A ElGabry; Cleopatra Kozlowski; Michael C Montalto; Anil V Parwani; Mark D Zarella; Douglas Bowman; David Rimm; Liron Pantanowitz Journal: Appl Immunohistochem Mol Morphol Date: 2021-08-01